Back to mobile site

BofA Securities Reiterates Neutral Rating on Edwards Lifesciences (EW)

October 30, 2024 4:03 PM EDT Send to a Friend
BofA Securities analyst Travis Steed reiterated a Neutral rating and $75.00 price target on Edwards Lifesciences (NYSE: EW).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login